价格

ID-001

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
- EP 4177264 A1
  申请人: IMMATICS BIOTECHNOLOGIES GMBH优先权: 2016
  EP
  US
  6 件公开
- US 10537624 B2
  申请人: IMMATICS BIOTECHNOLOGIES GMBH优先权: 2016
  CN
  US
  2 件公开
Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
US 8906681 B2申请人: KELLY JEFFERY W优先权: 2012
US
2 件公开
Human microRNAs for treatment of malignant tumours
US 10556019 B2申请人: UNIV JENA优先权: 2015
US
Targeting vector, recombinant Huh7 cell line, construction method and application
CN 114085868 A申请人: CANCER HOSPITAL CAMS优先权: 2020
CN
一种胞膜瞬时受体电位C6通道免疫原性短肽及其疫苗和抗心室纤维化的制药应用
CN 113072634 B申请人: 西安交通大学优先权: 2021
CN
Ginseng PgRb1-057-001 gene and application thereof
CN 114736910 A申请人: UNIV JILIN AGRICULTURAL优先权: 2022
CN
Application of fermented lactobacillus mucilaginosus in preparation of product for preventing or delaying Huntington's disease
CN 116173078 A申请人: PERFECT GUANGDONG COMMODITY CO LTD优先权: 2022
CN
一种缓解长春新碱致神经病理性疼痛的多肽及其应用
CN 116253778 B申请人: 中山大学优先权: 2023
CN
Polypeptide PDBPE-001 as well as pharmaceutical composition and application thereof
CN 116903721 A申请人: CHENGDU PEIDE BIOLOGICAL MEDICINE CO LTD优先权: 2023
CN
Chicken-derived lactobacillus salivarius and application thereof
CN 117736923 A申请人: UNIV SHIHEZI优先权: 2023
CN

药物

ID-001

专利

TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS